Combined Use of Respiratory Devices After Thoracic Surgery
Study Details
Study Description
Brief Summary
In a rehabilitation setting, respiratory muscle training with re-expansion techniques in patients following cardio-thoracic surgery represents a consolidated intervention. New devices called RESPILIFT® and RESPIVOl® improve deep inspiration and pulmonary volume with an effect on respiratory muscle performance and perceived dispnoea. The aim of the investigators study is to test the clinical efficacy of RESPILIFT® and RESPIVOl® in patients with a recent history of cardio-thoracic surgery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention Combined use of RESPIVOL® and RESPILIFT® (with resistive load) |
Device: Combined use of RESPIVOL® and RESPILIFT®
Active devices (combined) for 14 consecutive session, bid, for 15 minutes.
|
Sham Comparator: Control Combined use of RESPIVOL® and RESPILIFT® (without resistive load) |
Device: Combined use of RESPIVOL® and RESPILIFT®
Sham devices (combined) (without resistive load)for 14 consecutive session, bid, for 15 minutes.
|
Outcome Measures
Primary Outcome Measures
- Respiratory muscle performance [Change from Baseline in MEP at 6 months]
Change of MEP (Maximum Expiratory Pressure)measure
Secondary Outcome Measures
- Respiratory muscle performance [Enrollment (T0), Day 8 (T8), at the end (T14) and after 6 months (T6m)]
Change of MIP (Maximum Inspiratory Pressure)measure
- Pulmonary volumes [Enrollment (T0), Day 8 (T8), at the end (T14) and after 6 months (T6m)]
Change of Static and dynamic volumes (FEV1,FVC,VC,IC,RV)
- Pulmonary gas exchange [Enrollment (T0), at the end (T14) and after 6 months (T6m)]
Change of arterial oxygen(PaO2) and use of oxygen (FiO2) in terms of PaO2/FiO2
- Perceived dispnoea, well being and thoracic pain [At enrollment (T0), every day during the treatment (T2,T4, T6, T8, T10, T12), at the end (T14) and after 6 months (T6m)]
Change of perceived dispnoea, well being and thoracic pain measured through validated Visual Analogic Scale (VAS)
- Perceived quality of life [Enrollment (T0), at the end (T14) and after 6 months (T6m)]
Change of perceived quality of life through Saint George Respiratory Questionnaire (SGRQ), italian version
Eligibility Criteria
Criteria
Inclusion Criteria:
-
18 years old
-
recent cardio-thoracic surgery (< 30 days of admission)
-
compliance to pulmonary rehabilitation program
Exclusion Criteria:
-
clinical instability
-
concomitant severe co-morbidities
-
inability to use respiratory devices
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Villa Pineta Hospital | Modena | Italy | 41026 | |
2 | Villa Pineta Hospital | Modena | Italy |
Sponsors and Collaborators
- Villa Pineta Hospital
Investigators
- Study Director: Enrico E Clini, MD, University of Modena - Ospedale Villa Pineta
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- VP-02-2010